New cloud-native platform enables healthcare organizations to deploy AI-ECG algorithms across their entire ECG fleet.
HeartSciences today announced the general availability of MyoVista Insights, a cloud-native platform that enables healthcare organizations to deploy AI-powered ECG analysis across their entire ECG fleet, regardless of device manufacturer.
The platform represents a significant advancement in making AI-ECG technology accessible to healthcare providers of all sizes. Unlike traditional approaches that require specific hardware or proprietary systems, MyoVista Insights works with ECG devices from any manufacturer, including GE Healthcare, Philips, Nihon Kohden, and others.
Key Platform Features
MyoVista Insights includes several capabilities designed for enterprise healthcare deployment:
- Vendor-neutral device connectivity
- Multiple AI algorithms running simultaneously
- Native EHR integration via HL7 FHIR
- Real-time processing with results in under 30 seconds
- HIPAA compliance with SOC 2 Type II certification
"We built MyoVista Insights to remove the barriers that have prevented widespread adoption of AI-ECG technology," said the company's CEO. "Healthcare organizations shouldn't have to replace their ECG equipment or deal with complex integrations to benefit from AI analysis."